These emerging medications , Semaglutide , represent a groundbreaking advancement in managing metabolic dysfunction and potentially related ailments . These drugs are grouped as GLP-1 pathway https://hamzahljzs424181.blogerus.com/63359674/semaglutide-a-deep-exploration-into-glp-1-agents